Mark your calendars for Tuesday 29th October 2024, as BioMarin Pharmaceutical (NASDAQ: BMRN) is set to unveil its third quarter financial results. This highly anticipated announcement will be made after market close, giving investors and market participants a chance to assess the company's financial performance.
It is anticipated by financial experts on Wall Street that the business is set to announce an estimated $0.52 profit per share for the quarter. Additionally, the firm is expected to disclose a total revenue of $700.14 million for this period.
The projections from Wall Street analysts indicate that the company is expected to generate a total revenue of $2.8 billion for the full year. Moreover, they anticipate the earnings per share to reach profit of $2.07 during the fiscal year.
The company's earnings report for the same quarter in the previous year revealed a per-share income of $0.46, attributed to the company's total revenue of $581.33 million.
BMRN will host a conference call with investment community on 29th October 2024 at 04:30 PM eastern time to discuss the financial results.
Throughout Friday's trading, BioMarin Pharmaceutical (BMRN) shares fluctuated between $69.66 and $70.98, with a trading volume of 1.06 million shares. The stock ended the regular trading session at $69.73, reflecting drop of 0.94 percent.
